Cite Filings / EDIT / 0001193125-26-255480
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G

Statement of Beneficial Ownership

Editas Medicine, Inc. · Filed 2026-06-03 · Acc 0001193125-26-255480

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-06-05 4 SVP, Chief Financial Officer sold 464 shares at $2.70 ($1,253)
  • 2026-06-05 4 CEO sold 15,380 shares at $2.70 ($41,543)
  • 2026-06-05 4 EVP, CHIEF SCIENTIFIC OFFICER sold 731 shares at $2.70 ($1,975)
  • 2026-06-03 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-06-03 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-06-02 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-05-29 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…